Tuesday, September 15, 2026

Should Parents Bring Infants to the Movies? Shocking Incident Sparks Debate

A couple with a newborn disrupted a movie screening by feeding and burping the baby, causing discomfort among other viewers.

North Korea Human Rights Committee Disbanded: What This Means for 2026

The Ministry of Unification has dissolved the North Korean Human Rights Promotion Committee, redirecting funds to unification initiatives.

Nexon Unleashes KHAZAN in Early Access—Fans Are Loving It

Nexon launches early access for action RPG The First Berserker: KHAZAN, offering exclusive rewards and positive player feedback.

Tag: agency

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

U.S. Military Resumes COVID-19 Inspections: What This Means for South Korea in 2026

The Korea Disease Control Agency and the U.S. military will resume quarantine operations for military and contracted aircraft post-COVID-19.

Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion Market

Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.

How International Collaboration is Revolutionizing Infectious Disease Research in Asia

Korea's Disease Control Agency establishes a framework for local medical institutions to join international clinical trials for infectious diseases.

Smilegate Future Lab to Host AI Education Conference With MIT and Stanford Experts

Smilegate Future Lab will host an AI conference on June 20-21, featuring renowned scholars discussing AI's impact on education.

BA.3.2 Variant: Is This the New COVID-19 Threat for Asia?

The BA.3.2 COVID-19 variant is spreading globally, prompting health authorities to urge vaccinations for high-risk individuals.

This 10-Foot Robot Fights Fires So Humans Don’t Have To

The 2025 International Fire Safety Expo showcased an unmanned firefighting robot by Hyundai Rotem, enhancing fire response capabilities.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.